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INTRODUCTION AND REVIEW OF LITERATURE 
The diagnosis, treatment, and acceptance of outcome for childhood 
cancer may be a tragic complex of events not only for the patient but 
for the patient's family as well. To care for a dying child bespeaks an 
undeniably intensive level of psychological stress for these families. 
Childhood cancer has inherent psychological stresses for both the 
patient and their family. These stress factors have historically been 
related to death and the dying process. While treatment methodologies 
have greatly improved the expected life-span for many of these children, 
the remissions and relapses associated with this prolongation of life 
have added to the ambiguity with which these patients and families must 
cope. 
Kaplan et al. (1973) found that families with a leukemic child were 
a high risk group psychologically. They noted 87 percent of the fami-
lies in their study failed to cope adequately with the consequences of 
childhood leukemia. This resulted in many personal problems in addition 
to the stress precipitated by the leukemia. This is compatible with 
Binger's (1969) findings which revealed the need for psychiatric inter-
vention for at least one family member in 50 percent of the families 
with a fatally ill child. As Holland (1977) pointed out, it is the 
family member closest to the patient who bears the strain of the illness 
with the patient. When the patient is a child this strain is borne by 
one or both of the parents. A range of difficulties in coping and signs 
of psychological stress in parents of children with cancer have been 
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noted. Many parents utilize denial of the child's illness for varying 
lengths of time (Bozeman et al., 1955; Pearse, 1977; Stehbens and 
Lescari, 1975). Orbach et al. (1955) in their early work found greater 
magnitudes of rage and despair in the mothers of these children. 
Friedman (1967) and Adams (1978) also noted hostility and anger as often 
seen in these parents. Parents frequently feel guilt at not recognizing 
the disease sooner (Kirkpatrick, 1974; Friedman et al., 196)). Wright 
et al. (1979) speak of the feelings of helplessness of these parents 
due to their lack of control over their child's disease process. 
After the onset of the child's illness when support is needed most, 
it appears these parents tend to isolate themselves from friends and 
relatives while friends and relatives also abandom them (Bozeman et al., 
1955; Heffron et al., 1973; Pearse, 1977; Lansky, 1974). Parents are 
often deprived of luxuries as well as being stressed in meeting basic 
needs due to the financial burden of caring for their child with cancer 
(Lansky et al., 1979). 
While authors agree that there is significant psychological stress 
for these parents, what is needed is an improved understanding of this 
stress. As Wright et al. (1979) suggest, most of the behavioral 
data on these parents tends to be impressionistic and subjective. Very 
few studies have sought to quantify the behavior and level of psycho-
logical adjustment of these parents. This information would be impor-
tant not only for improvement of psychological management of these 
parents, but possible effects on the medical management of the child's 
illness. As Friedman (1967) pointed out, these parents must protect 
themselves from being overwhelmed to effectively function in both the 
medical and psychological management of their child. The focus of this 
review will be on the components of medical management which may be 
affected by the parent's psychological state. It is not the intent of 
this research project to investigate necessary psychological 
interventions. 
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A relatively broad approach to conceptualizing psychological fac-
tors which affect medical management has been presented by Becker et al. 
(1972) in terms of a Health Belief Model. They explain this Health 
Belief Model in terms of an individual's views concerning susceptibility 
to a disease, severity of that disease, and the benefits and costs 
associated with the paths of action that could be taken to prevent it. 
Children of mothers who believed that her child was susceptible to the 
disease, that the disease was severe, and that the treatment was worth 
the cost consistently showed higher levels of compliance to the medical 
regimens. However, no study has undertaken the assessment of the Health 
Belief- Model for parents of pediatric cancer patients and its effect on 
the medical management of those children. 
Another factor found to affect compliance with medical management 
and which would be important for this population has to do with adequacy 
of coping mechanisms. Gillum and Barsky (1974) reported that those 
without adequate coping mechanisms could not harness their fear to 
organize and initiate action to counterattack the perceived threat but 
were instead immobilized by the threat. With the high level of stress 
parents of childhood cancer patients appear to be experiencing, this 
process might be expected to interfere with the provision of medical 
care for the child. 
Medical management of childhood cancer primarily utilizes chemo-
therapy. Chemotherapy often results in agents being combined to 
increase their therapeutic effect. Complicated dosage and schedules 
exist for many chemotherapetltic agents which allow the agents to exert 
their antineoplastic effect (Minich and Grindey, 1977). Therefore, the 
agent, dosage, and scheduling may be crucial to the successful outcome 
of treatment. This places the primary emphasis on the agent dimensions 
1n contrast to compliance with the regimens. The assumption which 
followed was that treatment failures were due to the drugs rather than 
to a lack of compliance. Only one study has evaluated levels of com-
pliance in a pediatric cancer population (Smith et al., 1979). This 
study found a striking 33 percent of the population not in compliance 
with their medication regimen. No study of a pediatric cancer popula-
tion has attempted to simultaneously study drug compliance and possible 
psychological factors related to that compliance. 
The present study sought to gain a more thorough understanding of 
parenis of pediatric cancer patients in a quantified manner utilizing 
standardized psychological instruments. It was expected that in compar-
isons with normal adult populations these parents would exhibit greater 
levels of tension and apprehension. It was also expected they would 
tend to be more isolated and to be more willing to give up control of 
decisions to others. 
Drug compliance for these children is an extremely important aspect 
of their medical regimen. Since studies have shown parent's personality 
and attitudes to play an important part in that compliance, drug com-
pliance for this population was measured for these children. Parents 
of compliant patients were compared with parents of noncompliant 
patients for possible differences. In addition to the standardized 
psychological measures, an experimental questionnaire was utilized which 
concerns the parent's adherence to the Health Belief Model discussed 
earlier. It was expected that parents of compliant patients would 
exhibit a greater adherence to the Health Belief Model, would be more 
relaxed and be better able to cope with their difficulties. 
It has been shown with other diseases that as time in remission 
lengthens, there are changes in how one views the illness and need for 
treatment (Sackett and Haynes, 1976). To examine this dimension with 
this population, parents studied when their children had been in 
remission less than six months were compared with parents studied when 
their child was in remission more than six months. It was expected 
that parents with children in remission longer might become less tense, 
less isolated, and become more willing to tru(e control of their 
decisions. 
The last subgroup analysis compared parents of patients who 
relapsed after testing to parents of patients who remained in remission 
throughout the study. At this time little is known as to possible 
personality traits or beliefs which might interact with a child's 
tendency to relapse. This analysis explored this dimension. 
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METHODOLOGY 
Subjects 
The subjects were the parents of 31 pediatric outpatients of the 
Hematology-Oncology clinic of a~lahoma Children's Memorial Hospital. 
Outpatients in this study ranged in age from six months through 17 years 
of age, were receiving at least one oral antineoplastic medication, were 
judged by the clinic physicians not to be in the acute phase of their 
disease, and returned to the clinic at one to three week intervals. 
Diagnoses included solid tumors and lympho-leukemic neoplasms. In each 
case the parent who was primarily involved in the child's treatment was 
tested resulting in responses from 30 adult females and 1 adult male. 
Procedure 
Each parent-subject was administered four evaluation instruments. 
The Sixteen Personality Factor (16 PF) Questionnaire (Cattell et al., 
1970) and Fundamental Interpersonal Relations Orientation - Behavior 
(FIRO-B) Questionnaire (Schultz, 1967) supplied information as to the 
informants preexisting personality structure and attitudes. To eval-
uate how the parent evaluates the relative importance of interval 
versus external control, the Rotter (1966) I-E locus of control scale 
was employed. Additionally, the parents were a&ninistered an experi-
mental questionnaire, the Medicine Information Satisfaction Survey 
(MISS), to assess their attitudes toward medication, medical health 
professionals, their child's illness and other facets of the Health 
Belief Model. The 16 PF, FIRO-B, and Rotter I-E were all administered 
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one time to each patient's parent at the beginning of the study. The 
MISS was administered at both the beginning and end of the study to 
assess possible changes in the parent's health belief model. 
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RESULTS 
Analysis #1 
Parents of Patients Compared to Normative Data 
The entire group of parents (n=31) responding in this study were 
compared to normative data by means of scores on the 16 PF, FIRO-B, and 
Rotter I- E. Student's t-values demonstrated significant differences 
between these two groups on five of the factors of the 16 PF and on four 
of the six FIRO-B scales. Scales of the 16 PF found to significantly 
differentiate the two groups were: (1) Factor E, Humble versus Assert-
ive, with these parents scoring more in the humble direction; (2) Factor 
M, Practical versus Imaginative, with parents scoring more in the prac-
tical direction; (J) Factor 0, Placid versus Apprehensive, parents' 
scores were greater in the apprehensive direction; (4) Factor Q2 , Group-
Dependent versus Self-Sufficient, with parents scoring more in the self-
sufficient direction; (5) Factor Q4 , Relaxed versus Tense, with parents 
scoring toward the tense dimension. Significant 16 PF factors and their 
associated t-values are listed in Table I. 
The four FIRO-B scales significantly differentiating these parents 
as a group from the general adult population were: (1) Expressed 
Inclusion, (2) Wanted Inclusion, (3) Expressed Control, and (4) Wanted 
Control. These parents admitted to wanting and expressing less inclu-
sion and control than did the comparison group. FIRO-B scales found to 
be significant and their associated t-values are given in Table II. Mean 
values for significantly differentiating factors of the 16 PF and FIRO-B 
are provided in Table III. 
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TABLE I 
VARIABLES SIGNIFICANTLY DIFFERENTIATING PARENTS OF 
PATIENTS FROM ADULTS IN Trffi GENERAL POPULATION 
Variable 
16 PF Factor E 
Humble versus Assertive 
16 PF Factor M 
Practical versus Imaginative 
16 PF Factor 0 
Placid versus Apprehensive 
16 PF Factor Q2 
Group-Dependent versus Self-Sufficient 
16 PF Factor Ql.i, 
Relaxed versus Tense 
*p < .02' df 
**p < .01, df 
27, t 
27, t 
2.4,73 
2. 771 
9 
t-Value 
3.64,9** 
2.705* 
2.877** 
TABLE II 
FIRO-B VARIABLES SIGNIFICANTLY DIFFERENTIATING PARENTS 
OF PATIENTS FROM ADULTS IN THE GENERAL POPULATION 
Variable 
FIRO-B EI 
Expressed Inclusion 
FIRO-B WI 
Wanted Inclusion 
FIRO-B EC 
Expressed Control 
FIRO-B WC 
Wanted Control 
*p < .02, df = 30, t = 2.457 
**p< .01, df = 30, t = 2-750 
***p< .001, df = 30, t = 3.646 
t-Value 
3.163** 
5-454*** 
2.987** 
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TABLE III 
MEAN VALUES OF FACTORS SIGNIFICANTLY DIFFEllliNTIATING 
PATIENTS' PARENTS FROM NO~~TIVE DATA 
Variable X Parents X Normative 
16 PF Factor E 4t. 54l 5-5 
16 PF Factor M 4t.29 5 5 
16 PF Factor 0 6.21 5-5 
16 PF Factor Q2 6.4t6 5-5 
16 PF Factor Ql,t 6.57 5-5 
FIRO-B EI 4t.O? 5-2 
FIRO-B WI 2.23 3.4t 
FIRO-B EC 1.32 J.1 
FIRO-B WC 3-87 5.1 
11 
Data 
Analysis #2 
Parents of Compliant Patients Versus 
Parents of Noncompliant Patients 
This division concerned adherence of the patients to their anti-
neoplastic medication regimen. Medication history interviews were 
conducted at three consecutive clinic visits with each parent by a reg-
12 
istered pharmacist. Compliance for each antineoplastic agent was based 
on the accuracy with which the patient adhered to the dosage and inter-
val prescribed. A compliance percentage was calculated for each drug 
by dividing the number of doses taken correctly by the number of doses 
prescribed. Patients were categorized as compliant if they complied 
with their medication schedule at the rate of 80 percent or above for 
each drug as suggested by the work of Meyers et al. (1975) as expected 
compliance for chronic illnesses. If their rate was less than 80 per-
cent for any of their prescribed antineoplastic drugs, they were con-
sidered noncompliant. Eight of the 31 parents tested were excluded from 
this analysis due to insufficient compliance information, an incomplete 
test battery or both. Of the 23 remaining subjects, 14 were the 
parents of compliant patients while 9 were parents of noncompliant 
patients. Compliance on individual medications ranged from o% to 100%. 
A step-wise discriminant function analysis with 1 and 21 degrees 
of freedom (Klecka, 1978) compared the subjects in these two groups. 
Twenty-four variables were used of which six were found to be individ-
ually significant in differentiating the two groups. These variables 
indicated that the parents of compliant patients and noncompliant 
patients' parents differed in the areas of: (1) 16 PF Factor H in which 
the parents of noncompliant patients showed themselves to be more shy 
and restrained than parents of compliant patients who were more 
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venturesome and spontaneous; (2) FIRO-B Expressed Affection with the 
parents of compliant patients expressing more affection than those of 
noncompliant patients; (J) 16 PF Factor N with parents of noncompliant 
patients scoring in the shrewd and calculating direction; (~) FIRO-B 
Expressed Inclusion with parents of compliant patients expressing more 
inclusion behavior; (5) FIRO-B Wanted Affection with parents of com-
pliant patients wanting more affection; (6) 16 PF Factor C with parents 
of compliant patients scoring more in the direction of emotionally 
stable and facing reality. These results with their associated F values 
are summarized in Table IV. 
Utilizing the step-wise process of the discriminant function anal-
ysis, a set of three predictor variables was generated which signifi-
cantly differentiated the two groups. These three variables were (1) 
16 PF Factor H, Shy versus Venturesome; (2) FIRO-B Expressed Affection; 
and (3) 16 PF Factor N, Forthright versus Shrewd. These variables, 
their associated F-values, and the significance level of the prediction 
system as each variable was added are given in Table V. 
Analysis #3 
Studied at< 6 Months in Remission Versus 
Studied at> 6 Months in Remiss ion 
For purposes of this analysis, parents were divided into those 
studied (tested) when their child's illness had been in remission six 
months or less and those parents who were studied (tested) when their 
child's illness had been in remission more than six months. The range 
of time in remission for these children was one month to thirty-two 
months at the time of testing. Only those parents whose child was in a 
first remission were used in this analysis. Of the 25 parents meeting 
14 
TABLE IV 
VARIABLES SIGNIFICANTLY DIFFERENTIATING PARENTS OF COMPLIANT 
PATIENTS FROM PARENTS OF NONCOMPLIANT PATIENTS 
Noncompliant 
Variable 
Comp.!_iant 
X X F-Step 0 
16 PF Factor I-I 
Shy versus Venturesome 
6.00 3.44 11.01 ** 
FIRO-B EA 
Expressed Affection 
16 PF Factor N 
Forthright versus Shrewd 
FIRO-B EI 
Expressed Inclusion 
FIRO-B if\ 
Wanted Affection 
16 PF Factor C 
Affected by Feelings versus 
Emotionally Stable 
*p < . 05, df - 1, 21; F == 4. 30 
* * p < . 0 1 , df 1 , 2 1 ; F "' 7 • 9 5 
4.21 
5.00 
4.57 
6.14 
TABLE V 
2.11 
7.11 
3.00 
3-67 
4.44 
DISCRIMINANT FUNCTION PREDICTOR VARIABLES FOR THE PARENTS OF 
COMPLIANT PATIENTS VERSUS PARENTS OF NONCOMPLIANT 
PATIENTS 
Variable F-Step 0 F-Entered Significance 
16 PF Factor I-I 11.01 11.013 0.0033 
FIRO-B E 
A 
7-349 12.919 0.0003 
16 PF Factor N 6.-668 16.774 0.0000 
7-349* 
6.668* 
4.947* 
4.617* 
4.613* 
d. f. 
1,21 
2,20 
3,19 
this criterion, 7 were studied at SlX months or less while 18 were 
studied at over six -months in remission. 
These two groups were compared utilizing a step-wise discriminant 
function analysis with 1 and 24 degrees of freedom. In this analysis 
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one variable was found which individually significantly differentiated 
the two groups. Factor N of the 16 PF demonstrated the parents of 
patients in remission less than six months at the time of the study 
scored more toward the forthright dimension than the parents of patients 
studied at more than six months in remission who scored more toward the 
shrewd dimension. Values for this segment of analysis #3 are given in 
Table VI. 
Chosen by the step-wise portion of the discriminant function 
analysis were five variables which combined to significantly differ-
entiate the two groups studied. These variables were: (1) 16 PF Factor 
N, Forthright versus Shrewd; (2) FIRO-B Expressed Control; (J) 16 PF 
Factor Q4 , Relaxed versus Tense; (4) 16 PF Factor F, Sober versus Happy-
Go-Lucky; (5) FIRO-B Wanted Inclusion. These predictor variables, their 
associated F-values, and the significance of the prediction system as 
each variable was added are given in Table VII. 
Analysis #4 
Remission Versus Relapse 
After testing, during the course of the study, seven of the parti-
cipating patients relapsed. Test data from the parents of these 
patients were compared with the parents of those 20 patients who remained 
in their first remission throughout the study. 
A step-wise discriminant function analysis was performed to compare 
the parents in these two groups. The analysis revealed no variables 
TABLE VI 
VARIABLE SIGNIFICANTLY DIFFERENTIATING PARENTS OF PATIENTS STUDIED 
AT LESS THAN SIX MONTHS IN REMISSION FROM PARENTS OF PATIENTS 
STUDIED AT MORE THAN SIX MONTHS IN REMISSION 
16 
Variable < 6 Mo. >6 Mo. F-Step 0 
16 PF Factor N 
l:.:.29 6.78 9.l:i:06* 
16 
Forthright versus Shrewd 
*p< .01, df = 1,24; F = 7.82 
TABLE VII 
DISCRIMINANT FUNCTION PREDICTOR VARIABLES FOR PARENTS OF PATIENTS 
STUDIED AT LESS THAN SIX MONTHS IN REMISSION VERSUS PARENTS 
OF PATIENTS STUDIED AT MORE THAN SIX MONTHS IN REMISSION 
Variable F-Step 0 F-Entered Significance 
PF Factor N 9.406 9.406 0.0055 
FIRO-B EC 1.929 6.524 0.0060 
16 PF Factor Q4 0.9129 5-671 0.0055 
16 PF Factor F 0.2364 5-094 0.0054 
FIRO-B WI 0.5J40 5.010 0.0043 
d. f. 
1, 23 
2,22 
3,21 
4,20 
5,19 
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which individually significantly differentiated the two groups. The 
step-wise portion provided six variables which combined to form a pre-
diction system which significantly differentiated the two groups. These 
six variables, all 16 PF Factors, were: (1) Factor Q1 , Conservative 
versus Experimenting; (2) Factor F, Sober versus Happy-Go-Lucky; (J) 
Factor I, Tough-minded versus Tender-minded; (4) Factor Q3 , Undisci-
plined versus Controlled; (5) Factor L, Trusting versus Suspicious; (6) 
Factor M, Practical versus Imaginative. Parents of patients who later 
relapsed scored more in the direction of conservative, sober, tough-
minded, controlled, trusting, and practical. These factors, their asso-
ciated F-values, and the significance of the prediction system as each 
variable was added are given in Table VIII. 
Analysis #5 
Individual MISS Items 
This analysis examined the ability of scores on individual MISS items 
to differentiate the two subgroups used in each of analyses #2, #3, and #4. 
These comparisons were accomplished by means of Student's t-tests. 
This analysis found no individual MISS items were significant in 
differentiating between parents of compliant patients versus parents of 
noncompliant patients, parents of patients studied at> 6 months versus 
parents of patients studied at< 6 months in remission, or parents of 
patients who maintained their remission throughout the study versus 
parents of patients who relapsed during the course of the study. 
Analysis t#) 
Pre-MISS Scores Versus Post-MISS Scores 
Scores on the MISS from its first administration at the beginning 
of the study were compared with MISS scores from its administration at 
16 
16 
16 
16 
16 
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TABLE VIII 
DISCRIMINANT FUNCTION PREDICTOR VARIABLES FOR PAl~NTS OF 
PATIENTS WHO RELAPSED AFTER TESTING VEHSUS PARENTS 
OF PATIENTS ~~0 REMAINED IN REMISSION AFTER 
TESTING 
Variable F-Step 0 F-Entered Significance 
PF Factor Q1 3.244 3.244 0.0838 
PF Factor F 2.540 2.249 o. 1273 
PF Factor I 1.260 1.905 0.1569 
PF Factor Q3 0.383 1. 881± 0.1490 
PF Factor L 2.323 2.397 0.0790 
PF Factor M o. 1455 2.663 0.0459 
18 
d. f. 
1,25 
2,24 
3,23 
4,22 
5,21 
6,20 
the end of the study. Student's t-tests for correlated measures were 
employed for these comparisons. 
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One MISS item showed a significant difference between pre-MISS and 
post-MISS scores. This was item number two concerning the parent's 
understanding of why the medication was given to their child. Parents 
reported an improved understanding at the conclusion of the study. For 
this item, t = J.Oo, df = 15, p < .01. 
DISCUSSION 
Results of this study indicate that parents of pediatric cancer 
patients are not grossly maladjusted nor highly deviant in personality. 
They have made some adjustments in their outlook and beliefs which allow 
them to cope with their situational stress. 
These results lend support to observations noted earlier (Admns, 
1978; Binger, 1969; Friedman, 1963; Pearse, 1977) that parents of pedi-
atric cancer patients as a group are more tense and isolated than parents 
in general. Considering the stress they are experiencing, it is not 
surprising that they were found to be more tense and apprehensive than 
normal control adults. It might also be expected that in order to cope 
with the situation in which they find themselves it would be necessary 
for them to direct their focus of energy and emotional resources within 
the family thereby leaving little energy for outside interactions, hence 
the isolation evidenced by these parents. Another dimension of coping 
would revolve around their lack of control of their child's illness. To 
attempt to assert and maintain control would be less adaptive in their 
situation than to place belief and control with others. These parents 
are evidencing less desire for control than the comparison group of 
adults. Another facet of positive coping could be the greater concern 
with practical issues which would be necessary for the daily management 
of their child's illness and which these parents are manifesting. 
These parents consistently endorsed items on the MISS in the direc-
tion of ascribing to the Health Belief Model. According to compliance 
20 
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work with this model (Becker et al., 1972; Becker et al., 1977a; Becker 
et al., 1977b; Radius et al., 1978), it would be expected that these 
parents would be more likely to carry through in the provision of medi-
cal treatment for their child. Since only those parents whose child was 
in remission were studied, all the parents in this study had stayed with 
medical treatment long enough to help bring their child through the 
acute phase of their illness. This would imply a selected set of 
parents, that is, those who have the belief system and coping skills to 
provide their child with treatment for the illness. Therefore, the 
profile we see of a parent who is more practical, and experiencing ten-
sion, apprehension, isolation, and reduced control is probably the 
profile of the parent who mobilized their emotional resources in such a 
way as to be more successful in coping with the child's illness. 
The stress experienced by these parents might be expected to be 
present in a more intense form for those parents whose child has most 
recently experienced the acute phase of their illness. These are the 
parents who most recently have attempted to cope with the threatened 
loss of their child. It was hypothesized that these parents would 
experience the feelings of stress, isolation, and need for control more 
intensely than those parents whose ~hildren had achieved a greater dis-
tance of time into remission. For the most part these hypotheses were 
supported. Parents with a child in remission less than six months were 
more tense, sober, less questioning, and expressing less control than 
parents whose child had been in remission more than six months. The only 
result counter to this idea was that of parents with a child in remission 
less than six months desired more inclusion with others than did the 
parents with a child more than six months removed from their acute 
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phase. While these parents desired more interaction with others, they 
were not involved in these interactions to a significantly greater extent 
than were the parents of the children more than six months into remis-
sion. One explanation might be that the parents who were less removed 
from their child's acute phase experience more need for support by means 
of interactions with others while still exhibiting the reduced inter-
action necessary for the conservation of their emotional resources, 
hence the greater desire for inclusion without a significant difference 
in the expressed inclusion level. 
Feelings as to interactions with others also proved to be important 
in the delineation of another subset of parents. In the comparison of 
parents of compliant patients with those of noncompliant patients, the 
parents of noncompliant patients were significantly more constricted 
interpersonally than were parents of compliant patients. The parents 
of noncompliant patients were more shy, less forthright, interacted less 
with others, and desired less affection. They also showed themselves to 
be less emotionally mature. It appears that these parents may have a 
tendency to overreact In the sphere of isolation they appear to exceed 
what is necessary to adequately conserve needed emotional resources. 
This degree of constriction may prevent the kind of interaction necessary 
with the medical staff to assimilate adequate information and encourage-
ment for their child's proper compliance with medication regimens. In a 
clinic setting where necessary medication information was already being 
presented carefully, repetitively, and in a supportive and encouraging 
fashion, these parents were still reporting less than optimal compliance 
by their child. V.lben medication counseling with a registered pharmacist 
at each appointment and take-home medication calendars were added 
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(Cantrell, 1979), all but one of the parents of noncompliant patients 
who were still in remission· reported drug compliance improved to the 
point that their child could be classified as a drug compliant patient. 
It appears that these parents have the capacity to help these children 
comply but require greater and a different type of intervention than do 
the parents of already compliant patients. 
Parents of noncompliant patients subscribed to the Health Belief 
Model equally as well as parents of compliant patients as evidenced by 
the lack of significant differences on the MISS. This is contrary to 
what might be expected from reviewing previous work (Becker et al., 
1972; Becker et al., 1977a; Becker et al., 1977b; Radius et al., 1978) 
which showed compliant patients endorsing the Health Belief Model to a 
greater extent than noncompliant patients. However, as mentioned 
earlier the parents included in this study appear to be a select subset 
of those parents of children with cancer. These parents have evidenced 
by their behavior a belief in the efficacy of medical treatment. This 
idea of support for the Health Belief Model within this population is 
consistent with the lack of differences on the MISS among all the 
various subsets of this population which were tested. These beliefs 
also appear to be stable for this population. The only change noted 
between the MISS's administered at the beginning and the end of the 
study was an increased understanding of why the medication was given to 
the child. Considering that a portion of the study utilized repeated 
drug counseling with a registered pharmacist, this increased under-
standing is not unexpected. 
One set of findings in this study which must be interpreted with 
caution concerns differences between parents of patients who later 
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relapsed and parents of patients who remained in remission. Due to the 
small number of patients in the relapse group (n=?), the lack of vari-
ables which wer~ individually significant, and the paucity of even 
observational data in this area, information on the relapse group is 
considered very preliminary in nature. Results suggest that as a group 
the parents of patients who later relapsed are more conservative, sober, 
tough-minded, controlled, trusting, and practical. These data suggest 
the possibility of differences but testing information needs to be 
obtained on greater numbers of these parents before an interpretation 1s 
warranted. 
Results of this study have implications for both the medical and 
psychological management of the child with cancer and their parent. 
They suggest that the tension and isolation previously suspected does 
indeed exist for these parents. In an attempt to provide care to these 
children the staff must deal with a parent who is genuinely tense and 
apprehensive but not open to a great deal of interaction. This is 
especially true of parents of children in remission only a short period 
of time. While these parents of childhood cancer patients do not want 
to make their own decisions, neither are they willing for others to 
totally take control. 
It appears that the shyness and constriction parents of noncom-
pliant patients feel may keep them from seeking the information and 
encouragement they need to help their children increase their medica-
tion compliance Identification of and special attention to these 
parents appears necessary to maximize compliance. 
While this study has provided new information by a quantified 
examination of how parents of children with cancer function and has 
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quantified differences among parents of noncompliant patients, it has also 
pointed to the need for additional questions to be answered with appro-
priate modifications in design. An especially important question is how 
parents of children with cancer who do not maintain their child in treat-
ment differ from those parents who do continue treatment for their child. 
What are the differences between parents with a child in the acute phase 
as compared with parents in remission? Do differences in parents of 
children who later relapse and parents whose children remain in remission 
hold when greater numbers of these parents are studied? 
Future research in this area would be strengthened by the use of 
additional measures of medication compliance. Wl~ile it would be well to 
continue the use of structured medication interviews, the use of measures 
of actual medication levels in the body by blood and/or urine assays 
would add greater precision to these estimates. 
Another suggestion in the area of future research concerns the use of 
additional psychological evaluation. Structured interviews and the use 
of a projective measure such as the Thermatic Apperception Test would add 
a further dimension to the area of psychological functioning studied. 
The use of a more strongly normed test such as the California Personality 
Inventory might also prove advantageous. Additional information in this 
area might begin to answer the questions of helpful psychological inter-
ventions appropriate to these parents. However, judging from the inter-
personal constriction evidenced by the parents in the present study, the 
traditional approaches of a strong staff and/or group interventions may not 
be the treatment methods of choice. As these questions are addressed and 
information gained the goal of optimal medical and psychological manage-
ment of these patients and their families will be closer to realization. 
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CONSENT FORM 
--------------------------- , voluntarily consent for myself and I, 
my child, -----------------------------, to participate in the study entitled, 
11 Factors Affecting Compliance in a Pediatric Hematology-Oncology Popula-
tion111 and understand that the study will be as follows. 
1. The purpose of this project is to determine the extent of 
acceptance of the medical regimens prescribed by the physician and the 
factors which may affect acceptance. Behavioral, psychological, and 
medical information are to be collected to aid in understanding your 
view of the medications and its effects. This information will assist 
in developing procedures for increasing a child's compliance in follow-
ing the necessary regimen. 
2. The procedures used in this study have been adapted from pre-
vious work involving other medical problems. The questionnaires and 
techniques are standardized, accepted scientific procedures from medical 
and psychological disciplines. Some of the procedures are investiga-
tional in purpose (for example, examining the personality of the 
patient). However, none are contrary to the regular control of your 
child's illness. There are no known or expected adverse effects of a 
parent's or a child's participation in this project. 
J. While this study has the complete support of the physicians 
and staff of the Hematology-Oncology clinic, they will not have access 
to any information that I or my child provide as related to my/my 
child's name. Al~ data will be released by group membership rather than 
with my/my child's name. Our participation in this study will consist 
of completing questionnaires at the beginning of the project, once 
during the project, and at the end of the project, returning medication 
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containers with each clinic visit, and at times being in contact with 
the project personnel by appointment, mail, or telephone. Ny child's 
participation will consist of completing questionnaires and providing 
information at his/her regularly scheduled clinic appointments. The 
hospital records concerning my child's illness will be made available to 
the project personnel. I understand that strict confidentiality will 
be observed of all data collected as a result of participation by my 
child or myself under the guidelines established by the Public Health 
Service and the American Psychological Association. Complete anon~nity 
will be preserved and no patient's names will be released with the data 
collected. The project will continue no longer than ten clinic visits. 
4. The participation in this study should help my child and me in 
managing his/her illness through a definite procedure to maximize com-
pliance to medical regimens. Through increased compliance, the control 
of the disease will hopefully improve. The information gained should 
also benefit other pediatric hematology-oncology patients. 
5. As noted above, there are no known or expected risks to me or 
to my child as a result of participating in this study. 
6. Should I and my child decline to participate in this study, 
medical treatment of the condition will continue in the manner hereto-
fore followed by them without discrimination or denial of services by 
caretakers. 
7. Whereas no assurance can be made concerning results that may be 
obtained (since results from investigational studies cannot be pre-
dicted), the principal investigator will take every precaution con-
sistent with the best medical psychological practice. By signing 
this consent form, I have not waived any of my legal rights or released 
this institution from liability for negligence. I may revoke my con-
sent and withdraw from this·study at any time. Should any problems 
arise during this study, I may take them to: 
The Director of Research Administration 
Room 362, Biomedical Sciences Building 
Telephone: 271-2090 
Patient's Name 
Signature of Witness 
Jeannie Masters 
Pat Cantrell 
Principal Investigators 
H. Steven Caldwell, Ph.D. 
L. Kay See, N.S. 
Investigators 
Signature of Parent or Legal 
Guardian of Patient 
Date 
OKLAHONA CHILDREN'S MENORIAL 
HOSPITAL 
J2 
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16 PF, Rotter I-E, and FIRO-B Reliability, 
Validity and Normative Group Information 
16 Personality Factor 
Cattell believes that the most important of the several varieties 
of reliability coefficients is the "dependability coefficient: the 
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correlation between two administrations of the same test when the lapse 
of time is insufficient for people themselves to change with respect to 
what is being measured." Using this criterion, scale reliabilities 
ranged from 58 to 83 for Form A of the 16 scales. 
Concept validity is measured by correlating the scale with the 
factor it is supposed to measure. Utilizing this approach, scale 
I 
validities ranged from a low of 53 to a high of 94 on the 16 scales. 
Raw scores from the 16 PF are converted to sten scores from 1 
through 10, with the population average fixed at sten 5.5. Stens 5 and 
6 extend, respectively, a half standard deviation below and above the 
mean. Females from the group of parents tested were compared with 
norms based on age JO years and created by the testing of 729 young 
women using Form A of the 16 PF. The one male parent's score was 
compared with norms based on age 30 years and created from the testing 
of 2,255 young men on Form A of the 16 PF. 
(Reliability and validity information taken from Handbook 
for the 16 PF, 1970. Normative information from the Tabular 
Supplement No.1 to the 16 PF Handbook, 1967-68 Norms.) 
Rotter I-E 
In Rotter's 1966 work he reviews eight studies which show the 
reliability of his I-E to range from .49 to .79. His studies of 
validity correlating the I-E with the Marlowe-Croune Social Desir-
ability Scale ranged from -.07 to -.35 and from -.22 to .OJ with 
35 
intellectual measures indicating a good discriminant validity. He 
says that the trmost significant evidence of the construct validity of 
the I-E scale comes from predicted differences in behavior for indi-
victuals above and below the median of the scale or from correlations 
with behavioral criteria." This group of parents scores were tested 
against his group of 605 female undergraduates at Ohio State University 
whose mean score was 8.42 with a standard deviation of 4.06. 
FIRO-B 
Reliability of the FIRO-B by means of test-retest stability ranged 
from .71 to .82 with a mean coefficient of .76 for the six scales. 
Coefficients of internal consistency produced a mean of .94 for the six 
scales. 
According to Schultz (1967) "if the theory underlying the use of 
Guttman scales is accepted, then content validity is a property of all 
legitimate cumulative scales, and therefore of all FIRO-B scales. tr 
The FIRO-B has no overall population norms. as the authors believe 
it more meaningful to examine how individual groups manifest themselves 
on the dimensions of the FIRO-B. After consultation with the publishers 
of the FIRO-B (Consulting Psychologists Press, Inc.), it was decided 
that the group closest 1n make-up to the group of parents tested was a 
group of 677 teachers. The majority of these teachers were female and 
a parent. Their scores on the six scales were as follows: 
Scale M SD 
EI 5.2 1.96 
WI 3.4 3.42 
Ec 3.1 2.38 
we 5.1 1.93 
EA 3-7 2.07 
~ 4.3 2.36 
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Medicine Information Satisfaction Survey 
On the following pages you will be asked to read statements. 
Below each statement you will find: 
Totally 
False 
0 
Totally 
Incomplete 
0 
1 
1 
2 3 
OR 
2 3 
5 
5 
Totally 
True 
6 
Totally 
Complete 
6 
Please circle the number closest to your belief about the statement. 
For example, if you read a statement and completely agreed with it you 
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would circle 6. If you completely disagreed with it you would circle 0. 
Or if in another statement the term Totally Complete best fit your 
belief you would circle 6 while if Totally Incomplete best fitted your 
belief you would circle 0. If your belief is somewhere in between the 
two extremes, you would circle the number in between which best fitted 
your belief. Remember, circle the number which best fits your belief. 
Medicine Information Satisfaction Survey 
1. The information given me by the doctor about my (my child's) 
illness was: 
Totally 
Incomplete 
0 1 
2. I understand 
Totally 
False 
0 1 
2 3 
why this medication was given. 
2 3 
5 
5 
Totally 
Complete 
6 
Totally 
True 
6 
3. If this medication does not seem to be working, I will feel 
comfortable in talking to the doctor about it. 
Totally 
False 
0 1 2 3 5 
Totally 
True 
6 
4. The directions about my (my child's) medicine were: 
5-
6. 
Totally 
Incomplete 
0 1 
The medication 
Totally 
False 
0 1 
The medication 
Totally 
False 
0 1 
2 
given me (my 
2 
given me (my 
2 
3 
child) 
3 
child) 
3 
5 
Totally 
Complete 
6 
will cure this illness. 
5 
is only for this 
5 
Totally 
True 
6 
illness. 
Totally 
True 
6 
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7. The successful treatment of my (my child's) illness depends only 
on the medicine. 
Totally 
False 
0 1 2 3 5 
Totally 
True 
6 
8. Taking more than one kind of medicine shows that the doctors know 
what to do about this illness. 
Totally 
False 
0 1 2 3 5 
Totally 
True 
6 
9. Medicine prescribed for other illnesses have helped. 
10. 
11. 
Totally 
False 
0 
The medicine 
Totally 
False 
0 
The medicine 
that go with 
Totally 
False 
0 
1 2 
prescribed for 
1 2 
prescribed for 
it. 
1 2 
3 5 
this illness is worth 
3 4 5 
this illness is worth 
3 5 
Totally 
True 
6 
what it costs. 
Totally 
True 
6 
the problems 
Totally 
True 
6 
12. Following the exact directions about my (my child's) medicine is 
important. 
Totally 
False 
0 1 2 3 5 
Totally 
True 
6 
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13. Medicine is not as helpful when taken late. 
Totally Totally 
False True 
0 1 2 3 l1 5 6 
14. Taking an extra dose of medicine is harmful. 
Totally Totally 
False True 
0 1 2 3 5 6 
15. Forgetting to take a dose of medicine is harmful. 
Totally Totally 
False True 
0 1 2 3 5 6 
16. Unless the doctor's orders are followed my (my child's) illness 
may return. 
Totally 
False 
0 1 2 3 4 5 
Totally 
True 
6 
17. I feel my (my child's) doctor in this clinic has been warm and 
understanding in his dealings with me (my child). 
Totally 
False 
0 1 2 3 
18. I believe my (my child's) illness 1s ser1ous. 
Totally 
False 
0 1 2 3 
5 
5 
Totally 
True 
6 
Totally 
True 
6 
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19. I feel the staff in this clinic has been warm and understanding 
in their dealings with me (my child). 
20. 
Totally 
False 
0 1 
My (my child's) 
it would be. 
Totally 
False 
0 1 
2 
treatment 
2 
3 
in this clinic is 
3 
5 
Totally 
True 
6 
everything I hoped 
Totally 
True 
5 6 
41 
APPENDIX D 
MEANS AND STANDARD DEVIATIONS FOR ALL PARENTS 
ON THE 16 PF, FIRO-B, AND ROTTER I-E 
AND t-VALUES FOR ANALYSIS #1 
42 
43 
Means and Standard Deviations for All Parents 
on the 16 PF, FIRO-B, and Rotter I-E 
and t-values for Analysis #1 
Variable Mean Standard t-value 
Deviation 
16 PF Factor A 5-29 1.76 0.644 
16 PF Factor B 5.85 1.96 0.935 
16 PF Factor c 5-25 1.94 0.683 
16 PF Factor E 4.54 1.73 2.947** 
16 PF Factor F 4.93 1.84 1.623 
16 PF Factor G 5-25 1. 71 0-772 
16 PF Factor H 4.89 2.16 1.483 
16 PF Factor I 6.14 1.96 1. 738 
16 PF Factor L 5.61 1. 73 0.306 
16 PF Factor M 4.29 1. 76 3.649** 
16 PF Factor N 6.18 2.25 1.599 
16 PF Factor 0 6.21 1.40 2.705* 
16 PF Factor Q1 4.93 1. 78 1.696 
16 PF Factor Q2 6.46 1.99 2.564* 
16 PF Factor Q3 5.54 1. 88 0.101 
16 PF Factor Q4 6.57 1.97 2.877** 
FIRO-B EI 4.07 2.00 3.163** 
FIRO-B WI 2.23 2.57 2. 5Lx9* 
FIRO-B Ec 1.32 1.81 5.Lx54*** 
FIRO-B we 3-87 2.29 2.987** 
FIRO-B EA 3-55 2.19 0.386 
FIRO-B ~ 4.84 2.19 1.368 
Rotter I-E 9.63 3-67 1.591 
*p < .02 
**p< .01 
***p < .001 
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F-Values at Step 0 
Variable Analysis #2 Analysis #3 Analysis #11 
F-Value F-Value F-Value 
16 PF Factor A o.432 1.043 0. 816 
16 PF Factor B 0.649 1.360 0.816 
16 PF Factor c 4.613* 0.745 0.383 
16 PF Factor E 0.800 1.999 0.116 
16 PF Factor F 0.245 0.236 2.540 
16 PF Factor G 0.104 0.163 0.209 
16 PF Factor H 11.010** 0.584 0.561 
16 PF Factor I 0.168 0.646 1.260 
16 PF Factor L 0.450 1.612 2.323 
16 PF Factor M 0.488 0.815 0.146 
16 PF Factor N 6.668* 9.l.~:06 * * 0.383 
16 PF Factor 0 2.837 0.236 0.157 
16 PF Factor Q1 1.479 o.436 3.244 
16 PF Factor Q2 0.308 o.46o 0.383 
16 PF Factor Q3 0.708 1.525 0.629 
16 PF Factor Q4 0.310 o. 913 0.219 
FIRO-B EI 4. 91±7* 0.137 0.388 
FIRO-B WI 0.707 o.53l.~: 0.718 
FIRO-B Ec 0.710 1.929 0.101 
FIRO-B we 3.098 0.275 0.938 
FIRO-B EA 7-349* 0.599 0.301 
FIRO-B ~ 4. 617* 0.354 0.168 
Rotter I-E 0.161 0.289 0.314 
MISS 0.600 0.332 0.216 
*p < .05 
**p < .01 
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MISS Individual Item Means and 
Standard Deviations 
Item Compliant vs. Non- < 6 mo. vs. > 6 mo. Remission vs. Relapse 
No. compliant 
M SD M SD M SD M SD M SD M SD 
#1 5.66 0.61 5.70 0.48 s.so 0.76 s.63 0.60 5.55 0.67 5.86 0.38 
#2 5.66 0.62 5-70 0.48 5-63 0.52 5.58 0.61 5.59 0.59 5.71 0.49 
#3 5-93 0.26 5.10 2.02 5.86 0.35 5.26 1.82 5-55 1.41 5. 29 1. 89 
#4 5.87 0.35 5.90 0.31 5-75 0.46 5-95 0.23 5.86 0.35 6.00 0.00 
#5 3.40 1.63 2.80 1. 93 3-75 1.17 3.00 1.80 3.18 1.44 2.71 2.43 
#6 5.13 1. 77 5.30 1. 75 5-13 1.36 4.84 2.03 5.90 1.87 4. 71 1.60 
#7 1.40 1.84 2.70 2.00 2.88 1.64 2.10 2.05 2.09 1.95 3.00 1. 92 
#8 3-:1.3 2.26 3-30 2. 31 3-75 1. 98 3.2:1. 2.32 3-32 2.26 3·43 2.51 
#9 2.:1.3 2.56 4.10 2.23 2.50 2.83 2.89 2.40 2.77 2.56 2.86 2.61 
#10 6.00 0.00 5-70 0.95 6.00 0.00 5.84 0.69 5.86 0.64 6.00 0.00 
#1:1. 5.87 0.35 5-70 0.95 6.00 0.00 5-74 0.73 5.28 0.66 5.86 0.38 
#12 6.00 0.00 6.00 0.00 6.00 o.oo 6.00 o.oo 6:oo o.oo 6.00 0.00 
#:1.3 3-67 2.22 4.00 1.89 3-75 1.9:1. 3-79 2.12 3.4:1. 2.20 4.71 1.60 
#14 5.87 0.35 4.90 2-33 5.88 0.35 s.os 2.12 5.41 1.62 5. t4 2.27 
#15 4.67 1.40 L1. 50 1. 90 5-15 1.17 L1. 32 1.57 4.82 1.33 4.29 1.98 
#16 5-47 0.92 4.90 1.29 5-25 1.16 5. 16 1.17 5.18 1.37 4.71 1.38 
#17 5·53 1.36 s.6o o.96 s. 13 1.81 5-79 0.71 5-50 1.26 6.00 0.00 
#18 5-93 0.26 5.90 0.31 6.00 0.00 5.89 0.32 5-95 0.21 5.86 0.38 
#19 5.60 0.63 5.90 0.32 s.so 0.76 5.84 0.37 5.72 o.ss 5.86 0.38 
#20 5.53 0.7L1 s.8o o.42 5.38 0.74 5.680.67 5.64 0.66 5.57 0.79 
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Pre-MISS Minus Post-MISS Means, Standard 
Deviations, t-Values, and 
Signific;ances 
Item No. Mean Standard t-value Significances 
Deviation 
#1 0.00 l. 71 o.oo 1.000 
#2 0.38 o.so 3.00 0.009* 
#3 0.44 1.50 1.16 0.263 
#4 0.19 1.60 0.47 0.646 
#5 0.31 2.06 0.61 0.552 
#6 0.56 1.63 1.38 0.188 
#7 l.OO 1.90 2.11 0.052 
#8 0.94 2.46 1.52 0.149 
#9 0.06 J.43 0.07 0.943 
#10 0.00 0.00 
#11 0.50 1.55 1.29 0.216 
#12 0.00 0.00 
#13 0.38 2.09 0.72 0.485 
#14 0.44 1.60 1.10 0.289 
#15 0.06 1. 95 0. 13 0.900 
#16 0.50 2.10 0.95 0.355 
#17 0.19 0.75 1.00 0.333 
#18 0.00 o.oo 
#19 0.25 0.58 1.73 0.104 
#20 0.13 0.50 1.00 0.333 
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